Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT06935760
Eligibility Criteria:
Inclusion Criteria:
* Written Informed consent
* Adult aged ≥18 years
* English proficiency
* High BP defined as home SBP ≥135 or DBP ≥85 mmHg, either untreated or receiving one or two BP lowering drugs
* Among untreated individuals, indicated for pharmacological treatment of high BP according to 2023 Australian Heart Foundation Cardiovascular Risk Management Guidelines
* Willing to receive BP lowering drug treatment remotely if treatment is indicated
* Willing to check BP with home monitoring for 12 weeks
* Willing to participate in telehealth visit at baseline and 12 weeks
* Willing to undergo blood tests
Exclusion Criteria:
* Currently receiving three or more BP lowering drugs
* Currently receiving an antihypertensive that is not one of the five major antihypertensive drug classes
* Home SBP ≥155 mmHg for untreated participants
* Home SBP ≥150 mmHg for participants on one BP lowering drug
* Home SBP ≥145 mmHg for participants on two BP lowering drugs
* Baseline eGFR \<45 ml/min/m2
* Any abnormalities on baseline electrolytes that would prevent initiation of BP lowering therapy
* Participants with any other medical condition or taking any other concomitant medication which in the opinion of the investigator would make the participant unsuitable for the trial.
* Of childbearing age and not using contraception.
* Planned international travel for next 12 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06935760
Study Brief:
Protocol Section:
NCT06935760